Eli Lilly to license rheumatoid drug-making technology to Egypt’s EVA
Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to.
Drugs
Health
Pharma
Health
Medical
Pharma
FDA warns 8 firms for marketing harmful eye products
HQ Team September 12, 2023: The USFDA, in a bid to protect consumers, has issued warning letters to eight companies for marketing illegal.
Drugs
Health
Pharma
Viatris acquires two companies for $750 million to sharpen ophthalmology vision
Viatris acquires two companies for $750 million to fuel ophthalmology vision